Takashi Deguchi
Papers
1
Total Citations
6
H-Index
1
About
Takashi Deguchi is a cancer geneticist whose work illuminates the molecular underpinnings of renal cell carcinoma. His research centers on the chromosomal and mutational events that drive tumorigenesis, with a particular focus on the Von Hippel-Lindau (VHL) tumor suppressor pathway. In his landmark 2022 study, Deguchi demonstrated how derivative chromosome 3 loss from a t(3;6)(q12;q14) translocation, followed by differential VHL mutations, underlies the development of multifocal clear cell renal cell carcinoma (ccRCC). This work provides critical insight into how pVHL dysfunction—through impaired HIFα degradation—promotes tumor formation, advancing our understanding of ccRCC’s clonal evolution. Though early in his career, Deguchi’s contributions have already garnered attention, with his most cited paper accumulating 6 citations. His findings hold significant implications for cancer biology and precision oncology, offering a framework for dissecting the genetic heterogeneity of multifocal tumors. Deguchi’s meticulous approach to linking chromosomal aberrations with specific mutational landscapes marks him as a rising voice in the field of tumor suppressor gene research.
Research Focus
Key Achievements
Top Papers
- 1